Press release
ChemImage to Present Inkjet Discrimination Research Results at the 6th EDEWG Conference
ChemImage logo
A part of the European Network of Forensic Science Institutes (ENFSI), the European Document Experts Working Group supports ENFSI’s forensic document examination objectives. Held every two years, the 6th EDEWG Conference will offer workshops, scientific sessions and posters illustrating new developments in toner and ink examination.
The presentation, titled “Discrimination of Inkjet Printer Ink,” will examine HSI’s ability to link documents printed from different inkjet printers to a common manufacturer or ink formulation. Initial research found that the cyan, yellow and magenta components of each type of printer brand have their own unique spectroscopic responses.
HSI takes conventional photography and imaging methods to the next level by adding a spectroscopic basis for sample analysis. The result enables the identification and enhancement of contrast between chemically different materials.
In addition to the presentation, ChemImage will also be exhibiting throughout the conference’s duration.
For more information about the company’s activities at the 6th EDEWG Conference, visit http://www.chemimage.com/EDEWG.
About ChemImage
ChemImage Corporation, a leader in Hyperspectral Imaging technology (including Chemical and Molecular Imaging), provides instrumentation, software, contract services and expert consulting to government, industrial and academic organizations. The company’s proprietary, state-of-the-art Hyperspectral Imaging technology has many applications, including defense, security, pharmaceuticals, forensics and biomedical diagnostic research, which can reveal critical chemical and biological information from a variety of material systems.
ChemImage’s headquarters is located in Pittsburgh, Pennsylvania, where it houses research and development laboratories, as well as engineering and manufacturing facilities.
ChemImage Corporation
7301 Penn Ave.
Pittsburgh, PA 15208
412-251-7335
Media Contact: Suzanne Cibotti
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release ChemImage to Present Inkjet Discrimination Research Results at the 6th EDEWG Conference here
News-ID: 141875 • Views: …
More Releases from ChemImage Corporation
ChemImage Reports Advances in Characterization of Untreated Fingerprints
PITTSBURGH, Dec. 8, 2010 — ChemImage Corporation recently reported results from a hyperspectral imaging (HSI) study that displayed a 42.8% overall improvement in characterization of latent fingerprints in comparison to previous HSI image processing methods.
Improved data collection and image processing techniques were used to examine aged and recently deposited latent fingerprints on various surfaces that typically prove to be more difficult for forensic scientists, including white lined paper,…
ChemImage Reaches Agreement with Light Ace HK LTD to Distribute the FALCON II Sy …
PITTSBURGH, Aug. 23, 2010 — ChemImage Corporation recently reached an agreement with Light Ace HK LTD, a China-based distributor of laboratory equipment, instrumentation and services, to offer the Falcon II Wide-Field Raman Chemical Imaging System and select analytical contract services in China.
“This agreement affirms the value chemical imaging can bring to the international marketplace,” said Jim McGlone, president at ChemImage. “We look forward to working with Light Ace to develop…
Prediction of Prostate Cancer Progression Possible with Hyperspectral Imaging
PITTSBURGH, Aug. 11, 2010 — A study conducted by scientists at ChemImage Corporation, in partnership with a well-known U.S. medical research and treatment center, revealed that Raman Molecular Imaging (RMI), a type of hyperspectral imaging, has potential in predicting the progression of prostate cancer.
Blinded samples from 38 patients with Gleason score 7 prostate cancer were evaluated using RMI, an emerging technology that combines digital imaging and molecular spectroscopy to analyze…
ChemImage to Participate in the 37th Annual Meeting and Exposition of the Contro …
PITTSBURGH, May 17, 2010 — ChemImage Corporation will be presenting and exhibiting at the 37th Annual Meeting and Exposition of the Controlled Release Society, an international gathering focused on the science and technologies behind the delivery of bioactive agents, July 10-14 at the Oregon Convention Center in Portland, Ore.
“We’re really looking forward to participating in this year’s meeting and sharing some relevant findings about Raman chemical imaging’s (RCI) ability to…
